Skip to main content

Head-to-head comparison

2seventy bio vs tempus ai

tempus ai leads by 20 points on AI adoption score.

2seventy bio
Biotechnology R&D · cambridge, massachusetts
65
C
Basic
Stage: Exploring
Key opportunity: AI can accelerate the design and optimization of novel cell therapies by predicting protein-protein interactions and modeling T-cell receptor specificity, reducing costly experimental cycles.
Top use cases
  • AI-Powered Target Discovery
  • Predictive Biomarker Identification
  • Manufacturing Process Optimization
View full profile →
tempus ai
Biotechnology & Precision Medicine · chicago, illinois
85
A
Advanced
Stage: Mature
Key opportunity: Deploying multimodal foundation models to integrate genomic, clinical, and imaging data can accelerate biomarker discovery and enable real-time, personalized therapeutic recommendations for oncologists.
Top use cases
  • Predictive Biomarker Discovery
  • Clinical Trial Matching
  • Pathology Image Analysis
View full profile →
vs

Want a private comparison report?

We'll benchmark your company against up to 5 peers with a detailed AI adoption assessment.

Request report →